balance sheet

Costco may distribute a special dividend in 2026 given its $16.2B cash position and 2.75-year distribution pattern, though 50x valuation and tariff risks present headwinds.

Himax declares 25.2-cent dividend per ADS, paying out 100% of prior-year profits. CEO emphasizes healthy balance sheet and manufacturing strength.

$SBEV received NYSE delisting notice for failing equity requirements; pursuing Medterra CBD merger to restore compliance by January 2027.

B&G Foods offers an attractive 13% dividend yield, but excessive leverage and weak interest coverage make it a high-risk investment for most investors.

LiveOne corrected press release guidance for fiscal 2027, projecting $82M-$90M revenue and $5M-$10M adjusted EBITDA. Company completed $15M+ debt conversion and renewed major music partnerships.

Kevin Warsh, nominated Fed chairman, demands monetary policy overhaul to prevent future inflation crises, but faces structural obstacles to implementing lasting reform.

TSMC gains 26% YTD as the essential chipmaker for AI leaders Nvidia, AMD, and Broadcom, with fortress balance sheet and 35% revenue growth.

PrimeEnergy Resources reported 2025 revenue of $189.1M (down 20%), but net income of $26.3M ($15.85/share), supported by aggressive $PNRG share buybacks reducing shares from 7.6M to 1.6M while maintaining zero bank debt.

Battalion Oil posts record well results and 20.3% production jump after completing Monument Draw midstream project ahead of schedule and under budget.

ExxonMobil's fortress balance sheet and dividend aristocrat status—not oil prices—drive its investment case, offering downside protection competitors lack.

Watsco raises quarterly dividend 10% to $3.30, marking 52 consecutive years of payouts. Company invests in AI and digital platforms amid confident financial outlook.

BigBear.ai stock has declined significantly, but stronger financials, massive backlog, and policy tailwinds could drive future growth, suggesting potential oversold conditions.

$IDTA maintains profitability with $1.34M revenue and $99K net income in 2025, despite year-over-year declines, as it strengthens balance sheet for international growth.

SSR Mining jumps 17.5% on $1.5 billion Copler mine sale and 10% buyback program, signaling management confidence in undervalued shares.

Johns Hopkins economist Steve Hanke warns US federal government is technically insolvent with $47.78 trillion liabilities versus $6.06 trillion assets, excluding $136 trillion in unfunded obligations.

OceanPal Inc. reports $65.2M 2025 loss driven by digital asset markdowns, projects 2026 profitability for both shipping and NEAR token operations.

YY Group holdings announce $8.03 per share in assets and $3.18 net assets per share for fiscal 2025, citing AI integration and international growth.

Sarissa Capital deploys $5.79M in beaten-down biotech Biohaven despite 70% stock decline, betting on upcoming late-stage trial data and obesity candidate.

Aclarion outlines 2026 priorities: pursuing regional insurance reimbursement, releasing CLARITY trial results in Q4 2026, and expanding Nociscan adoption. Strong balance sheet extends to 2028.

Aclarion to present at ROTH Conference with debt-free balance sheet, outlining 2026 catalysts for Nociscan expansion in UK and US markets.